ArticleFrontiers in public health2025
Metabolome-wide associations with short-term exposure to PM
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Emerging evidence links fine particulate matter (PM Methods: In this study, we enlisted the participation of 112 healthy older adults. We employed personal samplers to monitor the concentrations of pollutants throughout the study period. Furthermore, we conducted an untargeted metabolomic analysis of plasma samples using a liquid chromatograph mass spectrometer (LC-MS). A general linear regression model was utilized to investigate the significant relationships between metabolites and pollutants. Metabolic pathway enrichment analysis was performed to reveal the disturbed metabolic pathways related to PM Results: Our study demonstrated that short-term exposure to PM Conclusion: The plasma metabolome presents a promising resource for biomarkers and pathways, elucidating the biological mechanisms of PM
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.